NeutriSci International Inc. Share Price OTC Markets

Equities

NRXCF

CA64129Y1079

Food Processing

Market Closed - OTC Markets 16:12:42 10/04/2024 BST 5-day change 1st Jan Change
0.0013 USD -.--% Intraday chart for NeutriSci International Inc. -.--% -.--%

Financials

Sales 2021 80.89K 59.13K 4.54M Sales 2022 458K 335K 25.7M Capitalization 2.64M 1.93M 148M
Net income 2021 -1M -731K -56.13M Net income 2022 - 0 0 EV / Sales 2021 113 x
Net Debt 2021 29.29K 21.41K 1.64M Net Debt 2022 3.36K 2.46K 189K EV / Sales 2022 5.77 x
P/E ratio 2021
-5.55 x
P/E ratio 2022
-3.23 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 98.97%
More Fundamentals * Assessed data
Dynamic Chart
NeutriSci International Inc. will Change its Ticker to NU.H from NU CI
NeutriSci International Inc. Primary Exchange Listing will Change to TSX Venture Exchange - Nex from TSX Venture Exchange CI
NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
NeutriSci International Inc. Announces Board of Director Changes CI
NeutriSci International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NeutriSci International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NeutriSci International Inc. Provides Update to Product Arrangement with Gaia Grow Corp CI
NeutriSci International Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NeutriSci International Inc. Auditor Raises 'Going Concern' Doubt CI
NeutriSci International Inc. announced that it has received CAD 0.196774 million in funding CI
NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
NeutriSci International Inc. announced that it expects to receive CAD 0.25 million in funding CI
NeutriSci International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
NeutriSci Announces Distribution Start of neuenergy in Europe CI
NeutriSci Shipped Order to Tabletz Distribution Partner; Up 25.8% in Early Frankfurt Trading MT
More news
Current year
0.00
Extreme 0.0013
0.01
1 year
0.00
Extreme 0.0012
0.01
3 years
0.00
Extreme 0.0012
0.11
5 years
0.00
Extreme 0.0012
0.27
10 years
0.00
Extreme 0.0012
0.27
More quotes
Managers TitleAgeSince
Chief Executive Officer - 31/12/09
Director of Finance/CFO 62 -
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 31/12/09
Director/Board Member - 25/11/14
More insiders
NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the development, formulation, and production of products for its business-to-business (B2B) partners around the globe. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.
More about the company